Table 1.

Baseline characteristics of patients with NLPHL

CharacteristicResultData available
Median age at diagnosis (range), years 41 (16-73) 59 
Male (%) 44 (75) 59 
Histologic type (%)  59 
 Typical (A/B) 36 (61) 
 Variant (non-A/B) 19 (32) 
 Histologic transformation at diagnosis 4 (7) 
 DLBCL 3 (75) 
 TCRBCL 1 (25) 
Albumin <4.0 g/dL (%) 7 (13) 55 
GHSG score  59 
 Low risk (0-1) 14 (24%) 
 Intermediate risk (2) 28 (48%) 
 High risk (3-4) 17 (29%) 
Stage (%)  59 
 I 12 (20) 
 II 25 (42) 
 III 14 (24) 
 IV 8 (14) 
ECOG performance status (%)  53 
 0 33 (62) 
 1 20 (38) 
B symptoms (%) 8 (14) 59 
Extranodal sites of involvement (%) 9 (15) 59 
Spleen involved (%) 8 (14) 59 
Bone marrow involved (%) 5 (8) 59 
CharacteristicResultData available
Median age at diagnosis (range), years 41 (16-73) 59 
Male (%) 44 (75) 59 
Histologic type (%)  59 
 Typical (A/B) 36 (61) 
 Variant (non-A/B) 19 (32) 
 Histologic transformation at diagnosis 4 (7) 
 DLBCL 3 (75) 
 TCRBCL 1 (25) 
Albumin <4.0 g/dL (%) 7 (13) 55 
GHSG score  59 
 Low risk (0-1) 14 (24%) 
 Intermediate risk (2) 28 (48%) 
 High risk (3-4) 17 (29%) 
Stage (%)  59 
 I 12 (20) 
 II 25 (42) 
 III 14 (24) 
 IV 8 (14) 
ECOG performance status (%)  53 
 0 33 (62) 
 1 20 (38) 
B symptoms (%) 8 (14) 59 
Extranodal sites of involvement (%) 9 (15) 59 
Spleen involved (%) 8 (14) 59 
Bone marrow involved (%) 5 (8) 59 
Close Modal

or Create an Account

Close Modal
Close Modal